Conmed (CNMD) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.59% |
| Dec 31, 2025 | 11.49% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 14.22% |
| Mar 31, 2025 | 7.38% |
| Dec 31, 2024 | 7.02% |
| Sep 30, 2024 | 7.27% |
| Jun 30, 2024 | 5.81% |
| Mar 31, 2024 | 5.61% |
| Dec 31, 2023 | 5.57% |
| Sep 30, 2023 | 5.24% |
| Jun 30, 2023 | 4.95% |
| Mar 31, 2023 | 2.36% |
| Dec 31, 2022 | 1.62% |
| Sep 30, 2022 | 0.73% |
| Jun 30, 2022 | -1.16% |
| Mar 31, 2022 | 4.44% |
| Dec 31, 2021 | 5.85% |
| Sep 30, 2021 | 5.01% |
| Jun 30, 2021 | 4.73% |
| Mar 31, 2021 | 4.13% |
| Dec 31, 2020 | 3.94% |
| Sep 30, 2020 | 5.03% |
| Jun 30, 2020 | 5.04% |
| Mar 31, 2020 | 6.83% |
| Dec 31, 2019 | 6.96% |
| Sep 30, 2019 | 6.26% |
| Jun 30, 2019 | 6.33% |
| Mar 31, 2019 | 5.98% |
| Dec 31, 2018 | 4.22% |
| Sep 30, 2018 | 4.17% |
| Jun 30, 2018 | 3.89% |
| Mar 31, 2018 | 3.83% |
| Dec 31, 2017 | 2.80% |
| Sep 30, 2017 | -0.17% |
| Jun 30, 2017 | -1.11% |
| Mar 31, 2017 | -1.13% |
| Dec 31, 2016 | -1.44% |
| Sep 30, 2016 | -0.46% |
| Jun 30, 2016 | -0.28% |
| Mar 31, 2016 | -0.86% |
| Dec 31, 2015 | -1.22% |
| Sep 30, 2015 | -1.40% |
| Jun 30, 2015 | -0.87% |
| Mar 31, 2015 | -0.72% |
| Dec 31, 2014 | 0.48% |
| Sep 30, 2014 | -0.94% |
| Jun 30, 2014 | -0.79% |
| Dec 31, 2013 | 1.11% |